Literature DB >> 23873311

The regulation and function of the NUAK family.

Xianglan Sun1, Ling Gao, Hung-Yu Chien, Wan-Chun Li, Jiajun Zhao.   

Abstract

AMP-activated protein kinase (AMPK) is a critical regulator of cellular and whole-body energy homeostasis. Twelve AMPK-related kinases (ARKs; BRSK1, BRSK2, NUAK1, NUAK2, QIK, QSK, SIK, MARK1, MARK2, MARK3, MARK4, and MELK) have been identified recently. These kinases show a similar structural organization, including an N-terminal catalytic domain, followed by a ubiquitin-associated domain and a C-terminal spacer sequence, which in some cases also contains a kinase-associated domain 1. Eleven of the ARKs are phosphorylated and activated by the master upstream kinase liver kinase B1. However, most of these ARKs are largely unknown, and the NUAK family seems to have different regulations and functions. This review contains a brief discussion of the NUAK family including the specific characteristics of NUAK1 and NUAK2.

Entities:  

Keywords:  AMP-activated protein kinase (AMPK); AMPK-related kinase; ARK5; LKB1; NUAK family; sucrose-non-fermenting protein kinase (SNF1)/AMPK-related kinase (SNARK)

Mesh:

Substances:

Year:  2013        PMID: 23873311     DOI: 10.1530/JME-13-0063

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  30 in total

1.  Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.

Authors:  Lakshmi Reddy Bollu; Jonathan Shepherd; Dekuang Zhao; Yanxia Ma; William Tahaney; Corey Speers; Abhijit Mazumdar; Gordon B Mills; Powel H Brown
Journal:  NPJ Breast Cancer       Date:  2020-01-03

2.  The AMPK-related kinase SNARK regulates muscle mass and myocyte survival.

Authors:  Sarah J Lessard; Donato A Rivas; Kawai So; Ho-Jin Koh; André Lima Queiroz; Michael F Hirshman; Roger A Fielding; Laurie J Goodyear
Journal:  J Clin Invest       Date:  2016-02       Impact factor: 14.808

3.  Lanthanum Chloride Induces Axon Abnormality Through LKB1-MARK2 and LKB1-STK25-GM130 Signaling Pathways.

Authors:  Zeli Song; Haoyue Mao; Jinxuan Liu; Wenchang Sun; Shengwen Wu; Xiaobo Lu; Cuihong Jin; Jinghua Yang
Journal:  Cell Mol Neurobiol       Date:  2022-06-05       Impact factor: 5.046

4.  MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.

Authors:  Masanori Oshi; Shipra Gandhi; Michelle R Huyser; Yoshihisa Tokumaru; Li Yan; Akimitsu Yamada; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

5.  A Specialized Mechanism of Translation Mediated by FXR1a-Associated MicroRNP in Cellular Quiescence.

Authors:  Syed I A Bukhari; Samuel S Truesdell; Sooncheol Lee; Swapna Kollu; Anthony Classon; Myriam Boukhali; Esha Jain; Richard D Mortensen; Akiko Yanagiya; Ruslan I Sadreyev; Wilhelm Haas; Shobha Vasudevan
Journal:  Mol Cell       Date:  2016-03-03       Impact factor: 17.970

6.  Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer.

Authors:  Xiao-tian Ye; Ai-jun Guo; Peng-fei Yin; Xian-dong Cao; Jia-cong Chang
Journal:  Med Oncol       Date:  2014-06-19       Impact factor: 3.064

7.  Metabolic regulator LKB1 is crucial for Schwann cell-mediated axon maintenance.

Authors:  Bogdan Beirowski; Elisabetta Babetto; Judith P Golden; Ying-Jr Chen; Kui Yang; Richard W Gross; Gary J Patti; Jeffrey Milbrandt
Journal:  Nat Neurosci       Date:  2014-09-07       Impact factor: 24.884

8.  Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model.

Authors:  Cristian A Lasagna-Reeves; Maria de Haro; Shuang Hao; Jeehye Park; Maxime W C Rousseaux; Ismael Al-Ramahi; Paymaan Jafar-Nejad; Luis Vilanova-Velez; Lauren See; Antonia De Maio; Larissa Nitschke; Zhenyu Wu; Juan C Troncoso; Thomas F Westbrook; Jianrong Tang; Juan Botas; Huda Y Zoghbi
Journal:  Neuron       Date:  2016-10-06       Impact factor: 17.173

Review 9.  Role of ARK5 in cancer and other diseases (Review).

Authors:  Guoheng Mo; Bohan Zhang; Qunguang Jiang
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447

Review 10.  Targeting Apoptosis in Cancer.

Authors:  Puneet Singh; Bora Lim
Journal:  Curr Oncol Rep       Date:  2022-02-03       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.